These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


394 related items for PubMed ID: 10661481

  • 1. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C, Grill A, Decostanzi E, Maddalena E, Barbieri S, Martina G, Fop F, Buglione E, Grechi D, David O, Saitta M, Piccoli G.
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [Abstract] [Full Text] [Related]

  • 2. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M, Walter H, Thies K, Anders C, Stein M, Hellstern P, Brass H.
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [Abstract] [Full Text] [Related]

  • 3. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 4. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 5. Zinc protoporphyrin/heme as an indicator of iron status in NICU patients.
    Juul SE, Zerzan JC, Strandjord TP, Woodrum DE.
    J Pediatr; 2003 Mar; 142(3):273-8. PubMed ID: 12640375
    [Abstract] [Full Text] [Related]

  • 6. Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients.
    Aljama P, Ward MK, Pierides AM, Eastham EJ, Ellis HA, Feest TG, Conceicao S, Kerr DN.
    Clin Nephrol; 1978 Sep; 10(3):101-4. PubMed ID: 699405
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
    Arndt U, Kaltwasser JP, Gottschalk R, Hoelzer D, Möller B.
    Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
    [Abstract] [Full Text] [Related]

  • 9. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M, Munaretto G, Spinello M, Rebeschini M, Amici G, Gallieni M, Piccoli A.
    J Nephrol; 2005 Mar; 18(1):72-9. PubMed ID: 15772926
    [Abstract] [Full Text] [Related]

  • 10. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH.
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [Abstract] [Full Text] [Related]

  • 11. Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study.
    Krafft A, Perewusnyk G, Hänseler E, Quack K, Huch R, Breymann C.
    BJOG; 2005 Apr; 112(4):445-50. PubMed ID: 15777442
    [Abstract] [Full Text] [Related]

  • 12. Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants.
    Miller SM, McPherson RJ, Juul SE.
    J Pediatr; 2006 Jan; 148(1):44-8. PubMed ID: 16423596
    [Abstract] [Full Text] [Related]

  • 13. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M, Salopek S, Möller M, Schliesser J, Klooker P, Reddig J, Gansert U, Brass H.
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [Abstract] [Full Text] [Related]

  • 14. Iron deficiency in the acute-phase reaction after open aortic surgery.
    Solis JV, Portero JL, Diaz J, Garcia R, Ligero JM, Vazquez E, Lodeiro C, Ballesteros L.
    Vasc Endovascular Surg; 2006 Mar; 40(5):392-8. PubMed ID: 17038573
    [Abstract] [Full Text] [Related]

  • 15. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
    Schoorl M, Schoorl M, Nubé MJ, Bartels PC.
    Clin Lab; 2006 Mar; 52(11-12):621-9. PubMed ID: 17175894
    [Abstract] [Full Text] [Related]

  • 16. [Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis].
    Matuszkiewicz-Rowińska J, Ostrowski G, Niemczyk S, Przedlacki J, Wardyn K, Puka J, Włodarczyk D, Switalski M, Zakrzewska T, Ostrowski K.
    Pol Arch Med Wewn; 2003 Jul; 110(1):703-10. PubMed ID: 14682204
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of iron deficiency in infancy with iron-acetyl transferrin].
    Careddu P, Mirra N, D'Angelo E, Carnelli V.
    Pediatr Med Chir; 1996 Jul; 18(2):155-60. PubMed ID: 8767577
    [Abstract] [Full Text] [Related]

  • 18. Comparative effectiveness of zinc protoporphyrin and hemoglobin concentrations in identifying iron deficiency in a group of low-income, preschool-aged children: practical implications of recent illness.
    Crowell R, Ferris AM, Wood RJ, Joyce P, Slivka H.
    Pediatrics; 2006 Jul; 118(1):224-32. PubMed ID: 16818569
    [Abstract] [Full Text] [Related]

  • 19. [Concentration of ferritin, transferrin and iron as a markers of iron deficiency in healthy women in reproductive age].
    Chełchowska M, Laskowska-Klita T, Leibschang J.
    Pol Merkur Lekarski; 2007 Jan; 22(127):25-7. PubMed ID: 17477085
    [Abstract] [Full Text] [Related]

  • 20. Zinc protoporphyrin, a useful parameter to address hyperferritinemia.
    Metzgeroth G, Schultheis B, Dorn-Beineke A, Hehlmann R, Hastka J.
    Ann Hematol; 2007 May; 86(5):363-8. PubMed ID: 17333188
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.